The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Technology, New Therapies Reduce Use of Addictive Prescriptions

October 28, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla., Oct. 28 /- The truth is...not all pain is created equal.  Acute pain is where it all begins.  Lasting for several months, acute pain is typically treated with rest, time and medication.  For many, that is enough.   But if the pain persists, it...


IRIDEX Announces Third Quarter 2010 Conference Call and Release Date

October 28, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 28 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that it will release its third quarter 2010 financial results after the market closes on Thursday, November 4, 2010.  In conjunction with the release, the Company will host a conference call with the...

FDA Approves Additional Medical Indication for Sprycel

October 28, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Oct. 28 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase...


Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

October 28, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology...

New Colorectal Screening Test Measures DNA Methylation

October 28, 2010 11:32 am | by AACR | News | Comments

PHILADELPHIA — Results from a validation study of a new DNA methylation screening tool for colorectal cancer will be presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held here Oct. 27-30, 2010.


FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability

October 28, 2010 11:32 am | by AACR | News | Comments

PHILADELPHIA — Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in...


Dentsply International's 3Q profit falls

October 28, 2010 10:45 am | by The Associated Press | News | Comments

Dental products maker Dentsply International Inc. said Thursday its third-quarter profit fell nearly 6 percent on higher costs.Dentsply said it earned $63.7 million, or 44 cents per share, down from $67.5 million, or 45 cents per share, a year earlier.Revenue rose 2 percent to $541.8 million...

Omnicare reports 3Q loss on charges

October 28, 2010 10:45 am | by The Associated Press | News | Comments

Omnicare Inc., which sells drugs to nursing homes and long-term care facilities, reported Thursday that it lost $103.3 million in its third quarter because its costs rose and it recorded charges for restructuring and other one-time expenses.The company lost $103.3 million, or 89 cents per...


Multiple sclerosis will become a controlled disease like AIDS

October 28, 2010 10:35 am | by EurekAlert | News | Comments

(IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer) In recent years around 20 genes related to Multiple Sclerosis have been identified. It is expected that in two years there will be about 80 identified genes that will properly define the disease genetic basis. The...

Aerospace and Defense OEMs Join with SME to Create AeroDef Manufacturing, New Expo, Educational Conference

October 28, 2010 10:34 am | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., October 27, 2010 — The Society of Manufacturing Engineers (SME) today announced the appointment of seven executive committee members for the AeroDef Manufacturing Exposition and Conference, to be held Tuesday–Thursday, April 5-7, 2011 at the Anaheim Convention...

North Shore biotech incubator launches

October 28, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The long-planned Biotech InnoVenture Center is launching in Beverly with a $50,000 grant from the Massachusetts Life Sciences Center and matching funds from private sources.

Power Supplies Offer Constant Current of 350 to 1,000 mA

October 28, 2010 9:54 am | Tumbler Technologies + TRUMPower | Product Releases | Comments

TRUMPower launches its 12 Watt LIS12 series of constant current AC/DC LED power supplies, which can efficiently drive high bright LEDs in series.

IV Flow Regulator Offers Easy, Accurate Adjustment

October 28, 2010 9:44 am | Qosina | Product Releases | Comments

The economical precision IV flow regulator from Qosina (Part #21293) has an easy-to-turn ridged dial that facilitates quick and accurate flow rate adjustment.

Custom Melt Filtration Offered for Catheter and Balloon Polymers

October 28, 2010 9:35 am | Product Releases | Comments

PolyMedex Discovery Group has expanded its range of custom material services by offering custom melt filtration of polymers used for catheters and balloons.

Small-molecule Inhibitors Effectively Targeted Active Colon Cancer Enzyme

October 28, 2010 9:34 am | by AACR | News | Comments

PHILADELPHIA — Researchers have identified two small-molecule inhibitors that effectively targeted the focal adhesion kinase (FAK), an enzyme present in certain cancers that helps tumors thrive and survive.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.